The Food and Drug Administration posted briefing materials for NPS
Pharmaceuticals Inc.'s (Nasdaq: NPSP) hormone replacement therapy Natpara
indicating that the drug was effective. The stock price leaped $6.47 to close at $32.24.
FDA posts favorable comments on NPS Pharmaceuticals' drug
September 10, 2014 at 18:08 PM EDT